Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Management of Hyperthyroidism

Initial Assessment and Diagnosis

  • Confirm hyperthyroidism by checking TSH and free T4 to complete the thyroid function panel, as recommended by the American College of Clinical Oncology 1
  • Evaluate for clinical symptoms of hyperthyroidism including weight loss, palpitations, heat intolerance, and hyperactivity, according to the American College of Clinical Oncology 2
  • Consider TSH receptor antibody testing if there are clinical features suggestive of Graves' disease, as suggested by the American College of Clinical Oncology 1
  • Assess for precipitating causes such as medication use, particularly amiodarone which can cause iodine-induced thyroid dysfunction, as noted by the American College of Clinical Oncology 2

Treatment Approach

  • Add a beta-blocker for symptomatic relief of adrenergic symptoms, as recommended by the American College of Clinical Oncology 1

Long-term Management Options

  • After 12-18 months of medical therapy, evaluate for possible discontinuation of anti-thyroid drugs if the patient achieves sustained euthyroidism, as recommended by the American College of Clinical Oncology 1
  • Consider definitive therapy options if hyperthyroidism persists or relapses, including radioactive iodine ablation and thyroidectomy, as suggested by the American College of Clinical Oncology 1
  • For persistent thyrotoxicosis despite appropriate medical therapy, endocrinology consultation is recommended, according to the American College of Clinical Oncology 1

Potential Pitfalls and Caveats

  • Patients with severe non-thyroidal illness may have altered thyroid hormone metabolism; careful clinical correlation is essential, as noted by the Praxis Medical Insights 2
  • Certain medications can affect thyroid hormone binding or metabolism, potentially causing misleading laboratory results, according to the Praxis Medical Insights 2
  • Patients with cardiac disease require close monitoring as hyperthyroidism significantly increases cardiovascular risk, as recommended by the Praxis Medical Insights 2

Indications for Endocrinology Referral

  • Unusual presentation or laboratory findings, such as elevated T3 with normal TSH, require endocrinology referral, as suggested by the Praxis Medical Insights 2
  • Poor response to standard therapy is an indication for endocrinology referral, according to the Praxis Medical Insights 2